Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.62 |
| ▸ | BRD4 | O60885 | 1/20 | 0.49 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29999040 | 1.00 | PARP1 (0.62) | PARP1BRD4CREBBPALDH1A1HPGD | |
| SCHEMBL19429612 | 1.00 | PARP1 (0.62) | PARP1BRD4CREBBPALDH1A1HPGD | |
| SCHEMBL14367228 | 0.79 | PARP1 (0.56) | PARP1BRD4CREBBPALDH1A1HPGD | |
| SCHEMBL3346129 | 0.79 | PARP1 (0.56) | PARP1BRD4CREBBPALDH1A1HPGD | |
| SCHEMBL4903088 | 0.79 | PARP1 (0.56) | PARP1BRD4CREBBPALDH1A1HPGD | |
| SCHEMBL3344870 | 0.79 | PARP1 (0.56) | PARP1BRD4CREBBPALDH1A1HPGD | |
| SCHEMBL7155529 | 0.77 | PARP1 (0.62) | PARP1BRD4CREBBPALDH1A1HPGD | |
| SCHEMBL13273256 | 0.77 | PARP1 (0.62) | PARP1BRD4CREBBPALDH1A1HPGD | |
| SCHEMBL7121791 | 0.77 | PARP1 (0.62) | PARP1BRD4CREBBPALDH1A1HPGD | |
| SCHEMBL1451025 | 0.77 | PARP1 (1.00) | PARP1BRD4CREBBPALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119861929-A | Office automation method based on visual arrangement and low code development, storage medium and electronic equipment | 江苏号百科技有限公司 | 2025-04-22 | — | — | CN | claimed |
| CN-116120688-B | Preparation method and application of benzoxazolinone type alkaloid molecularly imprinted polymer | 广东海洋大学 | 2024-04-16 | — | — | CN | claimed |
| EP-3447134-B1 | INCREASED FUNGAL RESISTANCE IN CROP PLANTS | KWS SAAT SE & CO KGAA (DE) | 2023-10-11 | — | — | EP | claimed |
| CN-116120688-A | Preparation method and application of benzoxazolinone type alkaloid molecularly imprinted polymer | 广东海洋大学 | 2023-05-16 | — | — | CN | claimed |
| US-20220387366-A1 | Compositions for Regulating Homeostasis of Cortisol and Improving Sleep Quality and Methods of Use and Production Thereof | UNIGEN, INC. (US) | 2022-12-08 | — | — | US | claimed |
| CN-119613717-B | Thermosetting polyimide resin with high heat resistance and preparation method thereof | SICHUAN UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-20260027699-A1 | Devices, Systems, and Methods for Adjusting Articulating Wearable Robot Parameters | UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2026-01-29 | — | — | US | disclosed |
| CN-119861929-A | Office automation method based on visual arrangement and low code development, storage medium and electronic equipment | 江苏号百科技有限公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-117105918-B | 1, 4-Benzoxazinone derivative with biological activity and preparation method and application thereof | 河南师范大学 | 2025-03-18 | — | — | CN | disclosed |
| CN-119627940-A | Optimal configuration method, system, equipment and medium for new energy power generation equipment | 国网浙江省电力有限公司温州供电公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-119613717-A | Thermosetting polyimide resin with high heat resistance and preparation method thereof | 四川大学 | 2025-03-14 | — | — | CN | disclosed |
| WO-2025030164-A1 | METHOD FOR PROMOTING PLANT GROWTH AND MODULATING PLANT ARCHITECTURE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-06 | — | — | WO | disclosed |
| US-20040209877-A1 | Methods for augmenting immune defenses contemplating the administration of phenolic and indoleamine-like compounds for use in animals ans humans | SEROCTIN RESEARCH & TECHNOLOGY, INC. | 2004-10-21 | — | — | US | disclosed |
| US-20040192669-A1 | Novel compounds for use in weight loss and appetite suppression in humans | SEROCTIN RESEARCH & TECHNOLOGY, INC. | 2004-09-30 | — | — | US | disclosed |
| US-20030187256-A1 | Benoxazinones/benzothiazinones as serine protease inhibitors | BERRYMAN KENT ALAN (US) | 2003-10-02 | — | — | US | disclosed |
| US-6509335-B1 | This invention discloses benzoxazinone and benzothiazinone compounds which display inhibitory effects on serine proteases such as factor Xa, thrombin, and/or factor VIIa. The invention also discloses pharmaceutically acceptable salts of | WARNER-LAMBERT COMPANY | 2003-01-21 | — | — | US | disclosed |
| EP-1068191-A1 | BENZOXAZINONES/BENZOTHIAZINONES AS SERINE PROTEASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2001-01-17 | — | — | EP | disclosed |
| WO-1999050257-A1 | BENZOXAZINONES/BENZOTHIAZINONES AS SERINE PROTEASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 1999-10-07 | — | — | WO | disclosed |
| WO-1998040504-A1 | METHODS FOR ALTERING BENZOXAZINONE LEVELS IN PLANTS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 1998-09-17 | — | — | WO | disclosed |
| WO-1993022441-A1 | DNA SEQUENCE OF A PLANT RESISTANCE GENE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1993-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192669-A1 | Novel compounds for use in weight loss and appetite suppression in humans | CPT1B, FABP4, EGLN1 | PARP1 2851/4885BRD4 423/4885CREBBP 325/4885 |
| US-20260027699-A1 | Devices, Systems, and Methods for Adjusting Articulating Wearable Robot Parameters | CREBBP, PIEZO1, FGFR2 | PARP1 810/4885BRD4 572/4885CREBBP 1/4885 |
| US-20040209877-A1 | Methods for augmenting immune defenses contemplating the administration of phenolic and indoleamine-like compounds for use in animals ans humans | HAAO, HMOX1, IDO1 | PARP1 2133/4885BRD4 822/4885CREBBP 829/4885 |
| US-20030187256-A1 | Benoxazinones/benzothiazinones as serine protease inhibitors | HABP2, SPINT2, SERPINB1 | PARP1 1395/4885BRD4 201/4885CREBBP 1139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.